TY - JOUR
TI - Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
AU - Chalkias, A.
AU - Mouzarou, A.
AU - Samara, E.
AU - Xanthos, T.
AU - Ischaki, E.
AU - Pantazopoulos, I.
JO - Molecular Diagnosis and Therapy
PY - 2020
VL - 24
TODO - 5
SP - 517-521
PB - Adis
SN - null
TODO - 10.1007/s40291-020-00481-8
TODO - C reactive protein;  urokinase receptor;  biological marker;  urokinase receptor, acute kidney failure;  algorithm;  Article;  chronic kidney failure;  coronavirus disease 2019;  cytokine storm;  focal glomerulosclerosis;  hospital admission;  human;  infection complication;  inflammation;  intensive care;  oxidative stress;  priority journal;  protein blood level;  systemic inflammatory response syndrome;  complication;  Coronavirus infection;  intensive care;  metabolism;  pandemic;  prognosis;  solubility;  virus pneumonia, Biomarkers;  Coronavirus Infections;  Critical Care;  Humans;  Pandemics;  Pneumonia, Viral;  Prognosis;  Receptors, Urokinase Plasminogen Activator;  Solubility
TODO - The novel coronavirus infection has spread worldwide, causing a wide spectrum of clinical manifestations. Most patients develop moderate clinical illness, but a substantial number will experience severe pneumonia, which may rapidly progress to acute respiratory distress syndrome and multiple organ failure. In this population, soluble urokinase plasminogen activator receptor (suPAR) could serve as a quick triage test and independent marker of clinical severity, hospital and intensive care unit admission, complications, and mortality. © 2020, Springer Nature Switzerland AG.
ER -